A testosterone lawsuit was filed in U.S. District Court in Northern Illinois (Chicago) against manufacturers of testosterone replacement therapy drugs, according to attorneys at the Onder Law Firm. The testosterone lawsuit, Case No. 1:2014cv08857, was filed on behalf of insurance companies who allege that deceptive marketing methods employed by testosterone manufacturers resulted in insurance companies spending billions of dollars on testosterone drugs that were ineffective for certain indications and ultimately unsafe, according to court documents.
Court documents show that initial testosterone lawsuit claims were filed on behalf of individuals alleging serious medical conditions such as a heart attack or stroke caused by the Androgel testosterone drug. Androgel lawsuits state pharmaceutical companies are liable to individuals for harmful medical conditions. This new testosterone lawsuit represents the interests of major insurance companies who believe they have sustained losses as a result of testosterone marketing practices.
Testosterone lawsuit claims have been consolidated as a multidistrict litigation (MDL) in the Northern District of Illinois, known as Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545. According to court documents, well over 200 testosterone lawsuit claims have been filed as a part of the MDL. The MDL includes claims related to a number of different testosterone drugs, including Androgel, sold by AbbVie, Inc.
Plaintiffs claim that serious health incidents including heart attack, stroke, deep vein thrombosis, and pulmonary embolism are linked to testosterone therapy. Androgel and related lawsuits claim consumers were not adequately warned of the risks associated with the treatment, and instead were subjected to misleading advertising regarding the efficacy of the drug.
The Ahearne Law Firm, PLLC provides national legal representation for men and their families who have experienced a heart attack, stroke, or other serious and life threatening medical conditions linked to testosterone therapy drugs.
People injured by testosterone therapy may be entitled to compensation.